By 10:25, the Sensex was lower by 405 points at 29,044 and the Nifty slipped 126 points at 8,812.
Among broader markets, BSE Midcap and Smallcap indices are down nearly 1%. Market breadth is weak with 1,211 declines against 649 advances.
Also Read
Investors would keenly await data on industrial production for January and consumer price index for February scheduled to be announced on Thursday.
Besides, developments in the ongoing session of Parliament will be closely watched.
On the currency front, the rupee plummeted by 50 paise to 62.66 against the US dollar in early trade today as the American currency strengthened overseas.
GLOBAL MARKETS
Asian stocks buckled while the dollar held firm on Monday after strong US jobs data fanned expectations that the US Federal Reserve may raise interest rates sooner than previously thought.
Stock markets across Asia, including Japan's Nikkei, Australia, Malaysia and Indonesia fell broadly, with MSCI's broadest index of Asia-Pacific shares outside Japan dropping 1.2%.
US non-farm payrolls (NFP) data on Friday showed the unemployment rate hit a 6-1/2-year low of 5.5% in February.
LEADERS & LAGGARDS
BSE Bankex and BSE IT index have slumped between 2- 2.1%. Sectors like Auto, Consumer Durables, Healthcare, Metal, Capital Goods, Realty and Power have declined between 1-1.7%.
Banking shares are witnessing profit booking after the recent run-up in stock prices. Axis Bank, ICICI Bank, HDFC Bank and SBI have dipped between 1-3%. Bank Nifty has slumped over 2% at 19,334 down 414 points.
TCS on Thursday said that the revenue in Q4 March 2015 is expected to be in-line with last year trend. Retail, manufacturing and Hi-Tech segments are recovering from muted Q3 December 2014, TCS said. TCS said there will be continued weakness in Diligenta, insurance, and energy businesses. Further, Religare has downgraded the stock to "hold" from "buy". TCS is down over 2%.
Other notable losers are GAIL, Sesa Sterlite, Hindalco, NTPC, Infosys and Tata Power.
Among other shares, Container Corporation of India is trading higher by 5% at Rs 1,562 on NSE in early morning deals after the Reserve Bank of India (RBI) has allowed foreign institutional investors (FIIs) to invest up to 34% of the paid-up capital in the company engaged in transport related services business.
Shares of Sun Pharma Research Company (SPARC) has zoomed 19% to Rs 562, extending its 15% rally past two trading days, after the company received approval from US Food and Drug Administration (USFDA) for antiepileptic drug.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)